194 related articles for article (PubMed ID: 27821443)
61. In vitro activity of antiretroviral drugs against Plasmodium falciparum.
Nsanzabana C; Rosenthal PJ
Antimicrob Agents Chemother; 2011 Nov; 55(11):5073-7. PubMed ID: 21876053
[TBL] [Abstract][Full Text] [Related]
62. Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics.
Cowell AN; Istvan ES; Lukens AK; Gomez-Lorenzo MG; Vanaerschot M; Sakata-Kato T; Flannery EL; Magistrado P; Owen E; Abraham M; LaMonte G; Painter HJ; Williams RM; Franco V; Linares M; Arriaga I; Bopp S; Corey VC; Gnädig NF; Coburn-Flynn O; Reimer C; Gupta P; Murithi JM; Moura PA; Fuchs O; Sasaki E; Kim SW; Teng CH; Wang LT; Akidil A; Adjalley S; Willis PA; Siegel D; Tanaseichuk O; Zhong Y; Zhou Y; Llinás M; Ottilie S; Gamo FJ; Lee MCS; Goldberg DE; Fidock DA; Wirth DF; Winzeler EA
Science; 2018 Jan; 359(6372):191-199. PubMed ID: 29326268
[TBL] [Abstract][Full Text] [Related]
63. Kinetic analysis of plasmepsins I and II aspartic proteases of the Plasmodium falciparum digestive vacuole.
Luker KE; Francis SE; Gluzman IY; Goldberg DE
Mol Biochem Parasitol; 1996 Jul; 79(1):71-8. PubMed ID: 8844673
[TBL] [Abstract][Full Text] [Related]
64. A single point mutation in the
Goodman CD; Uddin T; Spillman NJ; McFadden GI
Elife; 2020 Jul; 9():. PubMed ID: 32678064
[TBL] [Abstract][Full Text] [Related]
65. Impact of Field Isolate Identified Nonsynonymous Single Nucleotide Polymorphisms on
Sosa Y; Egbo D; Akabas MH
ACS Infect Dis; 2020 Feb; 6(2):205-214. PubMed ID: 31876139
[No Abstract] [Full Text] [Related]
66. HIV treatments reduce malaria liver stage burden in a non-human primate model of malaria infection at clinically relevant concentrations in vivo.
Hobbs CV; Neal J; Conteh S; Donnelly L; Chen J; Marsh K; Lambert L; Orr-Gonzalez S; Hinderer J; Healy S; Borkowsky W; Penzak SR; Chakravarty S; Hoffman SL; Duffy PE
PLoS One; 2014; 9(7):e100138. PubMed ID: 24988386
[TBL] [Abstract][Full Text] [Related]
67. HIV treatments have malaria gametocyte killing and transmission blocking activity.
Hobbs CV; Tanaka TQ; Muratova O; Van Vliet J; Borkowsky W; Williamson KC; Duffy PE
J Infect Dis; 2013 Jul; 208(1):139-48. PubMed ID: 23539746
[TBL] [Abstract][Full Text] [Related]
68. The zymogen of plasmepsin V from Plasmodium falciparum is enzymatically active.
Xiao H; Bryksa BC; Bhaumik P; Gustchina A; Kiso Y; Yao SQ; Wlodawer A; Yada RY
Mol Biochem Parasitol; 2014 Oct; 197(1-2):56-63. PubMed ID: 25447707
[TBL] [Abstract][Full Text] [Related]
69. A single S1034C mutation confers altered drug sensitivity to PfMDR1 ATPase activity that is characteristic of the 7G8 isoform.
Lekostaj JK; Amoah LE; Roepe PD
Mol Biochem Parasitol; 2008 Jan; 157(1):107-11. PubMed ID: 18006157
[TBL] [Abstract][Full Text] [Related]
70. The effect of antiretrovirals on Plasmodium falciparum liver stages.
Hobbs CV; De La Vega P; Penzak SR; Van Vliet J; Krzych U; Sinnis P; Borkowsky W; Duffy PE
AIDS; 2013 Jun; 27(10):1674-7. PubMed ID: 23907270
[TBL] [Abstract][Full Text] [Related]
71. Plasmodium DDI1 is a potential therapeutic target and important chromatin-associated protein.
Tanneru N; Nivya MA; Adhikari N; Saxena K; Rizvi Z; Sudhakar R; Nagwani AK; Atul ; Mohammed Abdul Al-Nihmi F; Kumar KA; Sijwali PS
Int J Parasitol; 2023 Mar; 53(3):157-175. PubMed ID: 36657610
[TBL] [Abstract][Full Text] [Related]
72. Essentiality of Plasmodium falciparum plasmepsin V.
Boonyalai N; Collins CR; Hackett F; Withers-Martinez C; Blackman MJ
PLoS One; 2018; 13(12):e0207621. PubMed ID: 30517136
[TBL] [Abstract][Full Text] [Related]
73. Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.
Sonoiki E; Palencia A; Guo D; Ahyong V; Dong C; Li X; Hernandez VS; Zhang YK; Choi W; Gut J; Legac J; Cooper R; Alley MR; Freund YR; DeRisi J; Cusack S; Rosenthal PJ
Antimicrob Agents Chemother; 2016 Aug; 60(8):4886-95. PubMed ID: 27270277
[TBL] [Abstract][Full Text] [Related]
74. A 4-cyano-3-methylisoquinoline inhibitor of Plasmodium falciparum growth targets the sodium efflux pump PfATP4.
Gilson PR; Kumarasingha R; Thompson J; Zhang X; Penington JS; Kalhor R; Bullen HE; Lehane AM; Dans MG; de Koning-Ward TF; Holien JK; Soares da Costa TP; Hulett MD; Buskes MJ; Crabb BS; Kirk K; Papenfuss AT; Cowman AF; Abbott BM
Sci Rep; 2019 Jul; 9(1):10292. PubMed ID: 31311978
[TBL] [Abstract][Full Text] [Related]
75. Genomic and biological features of Plasmodium falciparum resistance against antimalarial endoperoxide N-89.
Morita M; Hayashi K; Sato A; Hiramoto A; Kaneko O; Isogawa R; Kurosaki Y; Miyoshi SI; Chang KS; Wataya Y; Kim HS
Gene; 2019 Oct; 716():144016. PubMed ID: 31377318
[TBL] [Abstract][Full Text] [Related]
76. Exploiting Structural Dynamics To Design Open-Flap Inhibitors of Malarial Aspartic Proteases.
Bobrovs R; Jaudzems K; Jirgensons A
J Med Chem; 2019 Oct; 62(20):8931-8950. PubMed ID: 31062983
[TBL] [Abstract][Full Text] [Related]
77. Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.
Stokes BH; Yoo E; Murithi JM; Luth MR; Afanasyev P; da Fonseca PCA; Winzeler EA; Ng CL; Bogyo M; Fidock DA
PLoS Pathog; 2019 Jun; 15(6):e1007722. PubMed ID: 31170268
[TBL] [Abstract][Full Text] [Related]
78. Peptidomimetic plasmepsin inhibitors with potent anti-malarial activity and selectivity against cathepsin D.
Zogota R; Kinena L; Withers-Martinez C; Blackman MJ; Bobrovs R; Pantelejevs T; Kanepe-Lapsa I; Ozola V; Jaudzems K; Suna E; Jirgensons A
Eur J Med Chem; 2019 Feb; 163():344-352. PubMed ID: 30529637
[TBL] [Abstract][Full Text] [Related]
79. Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents.
Boss C; Richard-Bildstein S; Weller T; Fischli W; Meyer S; Binkert C
Curr Med Chem; 2003 Jun; 10(11):883-907. PubMed ID: 12678679
[TBL] [Abstract][Full Text] [Related]
80. Esterase mutation is a mechanism of resistance to antimalarial compounds.
Istvan ES; Mallari JP; Corey VC; Dharia NV; Marshall GR; Winzeler EA; Goldberg DE
Nat Commun; 2017 Jan; 8():14240. PubMed ID: 28106035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
